*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

Letrozole 2.5mg Tablet

Letrozole
2.5 mg
Tablet

ROA

Oral

Applicant Name

Novartis Nigeria Limited

NRN

B4-7680

Status

Active


ATC Code

L02BG04  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

3x10  

Product Description

19 RNW-PP-279263 Letrozole 2.5mg Tablet LETROZOLE Letrozole 2.5mg. Excipients - Colloidal anhydrous silica, microcristalline cellulose, lactose monohydrate, magnesium stearate, maize starch, sodium starch glycollate, hydroxypropyl methylcellulose, polyethylene glycol 8000, talc, titanium dioxide (E 171), iron oxide yellow (E 172) B4-7680 Drugs Imported Products 3x10 POM 2 9/7/2022 NOVARTIS NIGERIA LIMITED, LANDMARK BUILDING 52/54 ISAAC JOHN STREET IKEJA-GRA LAGOS LAGOS 2.34707E+12 nguavese.saror@novartis.com Novartis Pharma Stein AG, Novartis Pharma Stein AG Schaffhauserstrasse 4332 Stein AG, Switzerland, Switzerland

Manufacturer Name

Novartis Pharma Stein AG

Manufacturer Country

SWITZERLAND  

Approval Date

2023-05-25  

Expiry Date

2028-05-24